Skip to main content

Advertisement

Table 1 Patients’ baseline and tumor parameters

From: Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus

Parameter nCRT + S (n = 40) dCRT (n = 55) p-value
Age, (years)
 Median 65 68 0.079
 IQR 56–72 62–74
Male sex 22 (55%) 40 (73%) 0.085
T-stage (cT)
 Tis 0 (0%) 1 (2%) 0.148
 T1 1 (3%) 3 (5%)
 T2 7 (18%) 8 (15%)
 T3 32 (80%) 37 (67%)
 T4 0 (0%) 6 (11%)
N-stage (cN)
 N+ 40 (100%) 47 (85%) 0.019
Grading
 G1 1 (3%) 0 (0%) 0.729
 G2 20 (53%) 26 (53%)
 G3 17 (45%) 23 (47%)
Tumor length, (cm)
 Median 5 5 0.445
 IQR 3–7 4–7
Distance from dental arch to cranial tumor border, (cm)
 Median 26 20 < 0.001
 IQR 24–30 17–26
Tumor location
 Cervical 4 (10%) 26 (47%) < 0.001
 Thoracic 35 (88%) 28 (51%)
 Abdominal 1 (3%) 1 (2%)
Cumulative RT dose, (Gy)
 Median 41.4 54 < 0.001
 IQR 41.4–45 54–59.4
Complete tumor resection 36 (97%)
  1. IQR inter-quartiles-range, Gy Gray, RT radiotherapy